{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-({[({[(3R)-3-({2-[(2-{[(2E)-3-(3,4-dihydroxy-5-methoxyphenyl)prop-2-enoyl]sulfanyl}ethyl)carbamoyl]ethyl}carbamoyl)-3-hydroxy-2,2-dimethylpropoxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}methyl)-4-hydroxyoxolan-3-yl]oxy}phosphonic acid

• ChemBase编号: 3558
• 分子式: C31H44N7O20P3S
• 平均质量: 959.702243
• 单一同位素质量: 959.15746773
• SMILES: COc1cc(/C=C/C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n2cnc3c(N)ncnc23)cc(O)c1O
• Canonical SMILES: COc1cc(/C=C/C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(CO[P@](=O)(O[P@](=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2OP(=O)(O)O)O)n2cnc3c2ncnc3N)O)O)(C)C)O)cc(c1O)O
• InChI: InChI=1S/C31H44N7O20P3S/c1-31(2,26(44)29(45)34-7-6-20(40)33-8-9-62-21(41)5-4-16-10-17(39)23(42)18(11-16)53-3)13-55-61(51,52)58-60(49,50)54-12-19-25(57-59(46,47)48)24(43)30(56-19)38-15-37-22-27(32)35-14-36-28(22)38/h4-5,10-11,14-15,19,24-26,30,39,42-44H,6-9,12-13H2,1-3H3,(H,33,40)(H,34,45)(H,49,50)(H,51,52)(H2,32,35,36)(H2,46,47,48)/b5-4+/t19-,24-,25-,26+,30-/m1/s1
• InChIKey: ILSPFIPSQSFPCN-VYBUCKLUSA-N

名称和登记号

名称

• IUPAC标准名: {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-({[({[(3R)-3-({2-[(2-{[(2E)-3-(3,4-dihydroxy-5-methoxyphenyl)prop-2-enoyl]sulfanyl}ethyl)carbamoyl]ethyl}carbamoyl)-3-hydroxy-2,2-dimethylpropoxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}methyl)-4-hydroxyoxolan-3-yl]oxy}phosphonic acid
• IUPAC传统名: @feruloyl coenzyme A
• 别名: Feruloyl Coenzyme A

登记号

• PubChem SID: 46505207; 160966996
• PubChem CID: 44229079

理论计算性质

JChem

• Acid pKa: 0.8136809
• 质子受体: 20
• 质子供体: 11
• LogD (pH = 5.5): -8.671591
• LogD (pH = 7.4): -10.3194895
• Log P: -5.1473026
• 摩尔折射率: 213.0492 cm^3
• 极化性: 83.668335 Å^3
• 极化表面积: 413.32 Å^2
• 可自由旋转的化学键: 23
• 里宾斯基五规则: false

ALOGPS 2.1

• Log P: 0.25
• LOG S: -2.53
• 溶解度: 2.83e+00 g/l

详细说明

DrugBank - DB03923

Drug information: experimental